刘欣然 - 华中科技大学

个人简介

华中师范大学学士、硕士，中国科学院上海生命科学研究院博士。

研究领域

目前主要研究方向包括肿瘤的信号转导以及肿瘤的基因治疗等。近五年发表SCI论文超过10篇，单篇最高影响因子大于9。

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

1，Xinran Liu, Zhou, Y, Peng, A, Gong, H, Huang, L, Ji, K et al. MPHOSPH1: a potential therapeutic target for hepatocellular carcinoma. Cancer Research, 2014: 74: 6623-6634. 2,Xinran Liu, Hao Gong, Kun Huang: Oncogenic Role of Kinesin Proteins and Targeting Kinesin Therapy.Cancer Science, 2013;104:651-6. 3,Xinran Liu, Ying Cai, Xin Cao, Ruicheng Wei, Huiling Li, Xiumei Zhou, Kangjian Zhang, Shuai Wu, Qijun Qian, Biao Cheng, Kun Huang, Xinyuan Liu: A new oncolytic adenoviral vector carrying dual tumor suppressor genes shows potent antitumor effect.Journal of Cellular and Molecular Medicine, 2012; 16: 1298-309. 4,Xinran Liu, Xin Cao, Ruicheng Wei, Ying Cai, Huiling Li, Jianhua Gui, Dan Zhong, Xinyuan Liu, Kun Huang: Gene-Viro-Therapy targeting liver cancer by a dual regulated oncolytic adenoviral vector harboring IL-24 and TRAIL.Cancer Gene Therapy, 2012; 19 (1): 49-57. 5, Biao Cheng,Xinran Liu*,Hao Gong, Lianqi Huang, Hong Chen, Xin Zhang, Chuanzhou Li, Muyang Yang, Bingjun Ma, Lihua Jiao, Ling Zheng, Kun Huang: Coffee components inhibit the amyloid formation of human islet amyloid polypeptide in vitro: a possible link between coffee consumption and diabetes mellitus.Journal of Agricultural and Food Chemistry, 2011; 59 (24): 13147-55. 6，Ying Cai,Xinran Liu*,Weidan Huang, Kangjian Zhang, Xinyuan Liu: Synergistic antitumor effect of TRAIL and IL-24 with complete eradication of hepatoma in the CTGVT-DG strategy.Acta Biochim Biophys Sin, 2012; 44: 535-43.